ARTV
Price:
$3.775
Market Cap:
$92.66M
Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. The company's lead product candidate is AB-101, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody-associated vasculitis subtypes granulomatosis with polyangiitis/microscopic polyangiitis, systemic lupus erythematosus, and B-cell-non-Hodgkin lymphoma. It also develops AB-201, an allogeneic anti- human epidermal growth factor receptor 2 chimeric antigen receptor (...[Read more]
Industry
Biotechnology
IPO Date
2024-07-19
Stock Exchange
NASDAQ
Ticker
ARTV
According to Artiva Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.04. This represents a change of 38.02% compared to the average of -2.20 of the last 4 quarters.
The mean historical PE Ratio of Artiva Biotherapeutics, Inc. over the last ten years is -5.43. The current -3.04 PE Ratio has changed 5.50% with respect to the historical average. Over the past ten years (40 quarters), ARTV's PE Ratio was at its highest in in the September 2023 quarter at 2.49. The PE Ratio was at its lowest in in the December 2024 quarter at -6.66.
Average
-5.43
Median
-3.91
Minimum
-11.73
Maximum
0
Discovering the peaks and valleys of Artiva Biotherapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 179.14%
Maximum Annual PE Ratio = 0
Minimum Annual Increase = -Infinity%
Minimum Annual PE Ratio = -11.73
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -4.20 | -58.38% |
| 2023 | -10.09 | 179.14% |
| 2022 | -3.61 | 23.01% |
| 2021 | -2.94 | -74.95% |
| 2020 | -11.73 | -Infinity% |
The current PE Ratio of Artiva Biotherapeutics, Inc. (ARTV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-5.97
5-year avg
-6.51
10-year avg
-5.43
Artiva Biotherapeutics, Inc.’s PE Ratio is less than Precision BioSciences, Inc. (-0.71), less than Adverum Biotechnologies, Inc. (-0.48), less than Sutro Biopharma, Inc. (-0.37), less than Fractyl Health, Inc. Common Stock (-1.05), less than ALX Oncology Holdings Inc. (-0.63), less than InflaRx N.V. (-1.41), less than Zentalis Pharmaceuticals, Inc. (-0.62), less than Metagenomi, Inc. Common Stock (-0.76), greater than Connect Biopharma Holdings Limited (-3.90), greater than Shattuck Labs, Inc. (-3.91),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.71 | $66.54M | |
| -0.48 | $92.06M | |
| -0.37 | $79.86M | |
| -1.05 | $142.94M | |
| -0.63 | $74.28M | |
| -1.41 | $74.52M | |
| -0.62 | $101.15M | |
| -0.76 | $67.21M | |
| -3.90 | $141.98M | |
| -3.91 | $142.27M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Artiva Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Artiva Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Artiva Biotherapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Artiva Biotherapeutics, Inc. (ARTV)?
What is the highest PE Ratio for Artiva Biotherapeutics, Inc. (ARTV)?
What is the 3-year average PE Ratio for Artiva Biotherapeutics, Inc. (ARTV)?
What is the 5-year average PE Ratio for Artiva Biotherapeutics, Inc. (ARTV)?
How does the current PE Ratio for Artiva Biotherapeutics, Inc. (ARTV) compare to its historical average?